US 11135214
Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener
granted A61KA61K31/472A61K9/0053
Quick answer
US patent 11135214 (Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener) held by Xenon Pharmaceuticals Inc. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/472, A61K9/0053, A61P, A61P25/08